Abstract

The left atrium (LA) in heart transplant (HT) recipients is a surgically created chamber from variable portions of donor and recipient. In the non-HT patients there is strong evidence that left atrial volume (LAV) is a robust predictor of cardiovascular outcomes such as atrial fibrillation, stroke, heart failure and cardiovascular death. Thus, we thought to 1) characterize LA size in HT recipients and 2) investigate the implications of "new" LA volume on HT outcomes. First echocardiograms of 248 HT recipients between 2000-2018 were analyzed for LA volume index (LAVi). LAV was assessed employing the biplane Simpson method in the apical 4- and 2-chamber view and indexed to body surface area (LAVi). Patients were categorized by quartiles. The primary end points were: stroke, cardiovascular and all-cause mortality, cardiac allograft vasculopathy and heart failure. Mean and median LAV were 69.3 mL (SD, 29.6) and 65.3 mL [IQR 48.2, 84.3], respectively, and, when indexed (LAVi), 37.2 mL/m2 (SD, 15.7) and 34.6 mL/m2 [IQR 25.9, 45.6], respectively. Baseline patient and donor clinical, demographic and hemodynamic parameters were similar. Outcomes, assessed by each LAVi quartile were shown to have similar cumulative probabilities. Kaplan-Meier analyses for each outcome, were similar too (Figure). Notably, with an emphasis on the enlarged LA volume of this cohort, the hazard of stroke, was low. Consistent with these findings, atrial fibrillation episodes were very rare (excluding perioperative/rejection) with a total of 7 patients experiencing paroxysmal atrial fibrillation. In contrast to what is known in non-HT patients, no association was demonstrated for LAV and cardiovascular adverse events. As all patients undergo a "MAZE procedure" during HT, our findings suggest that pulmonary vein isolation and cardiac denervation provide significant prophylaxis against cardiovascular events in HT patients, neutralizing the risks that are typically associated with significant enlargement of LA volumes.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call